This is a news story, published by Investor's Business Daily, that relates primarily to McKesson news.
For more McKesson news, you can click here:
more McKesson newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
MCK stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest McKesson shares news, McKesson Ventures news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
McKesson EarningsInvestor's Business Daily
•
79% Informative
McKesson missed sales estimates for the June fiscal first quarter late Wednesday .
Its earnings topped views, with the help of stock buybacks.
McKesson cited a number of factors for the weaker-than-expected revenue, including a key customer's "shift from brand to biosimilar" for Humira , used to treat arthritis.
VR Score
81
Informative language
82
Neutral language
5
Article tone
formal
Language
English
Language complexity
33
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
2
Affiliate links
no affiliate links